Bioatla Cash And Cash Equivalents Changes from 2010 to 2024
| BCAB Stock | USD 1.57 0.09 5.42% |
Cash And Cash Equivalents Changes | First Reported 2010-12-31 | Previous Quarter -26.5 M | Current Value -25.2 M | Quarterly Volatility 13.9 M |
Check Bioatla financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bioatla's main balance sheet or income statement drivers, such as Net Interest Income of 6 M, Interest Income of 6 M or Depreciation And Amortization of 1.2 M, as well as many indicators such as Price To Sales Ratio of 2.6 K, Dividend Yield of 0.0 or PTB Ratio of 1.75. Bioatla financial statements analysis is a perfect complement when working with Bioatla Valuation or Volatility modules.
Bioatla | Cash And Cash Equivalents Changes |
Latest Bioatla's Cash And Cash Equivalents Changes Growth Pattern
Below is the plot of the Cash And Cash Equivalents Changes of Bioatla over the last few years. It is Bioatla's Cash And Cash Equivalents Changes historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bioatla's overall financial position and show how it may be relating to other accounts over time.
| Cash And Cash Equivalents Changes | 10 Years Trend |
|
Cash And Cash Equivalents Changes |
| Timeline |
Bioatla Cash And Cash Equivalents Changes Regression Statistics
| Arithmetic Mean | (313,824) | |
| Coefficient Of Variation | (4,420) | |
| Mean Deviation | 10,700,518 | |
| Median | 6,374,000 | |
| Standard Deviation | 13,869,773 | |
| Sample Variance | 192.4T | |
| Range | 35.8M | |
| R-Value | (0.69) | |
| Mean Square Error | 109T | |
| R-Squared | 0.47 | |
| Significance | 0 | |
| Slope | (2,134,395) | |
| Total Sum of Squares | 2693.2T |
Bioatla Cash And Cash Equivalents Changes History
About Bioatla Financial Statements
Bioatla stakeholders use historical fundamental indicators, such as Bioatla's Cash And Cash Equivalents Changes, to determine how well the company is positioned to perform in the future. Although Bioatla investors may analyze each financial statement separately, they are all interrelated. For example, changes in Bioatla's assets and liabilities are reflected in the revenues and expenses on Bioatla's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Bioatla. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Cash And Cash Equivalents Changes | -26.5 M | -25.2 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Bioatla offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bioatla's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bioatla Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bioatla Stock:Check out the analysis of Bioatla Correlation against competitors. For information on how to trade Bioatla Stock refer to our How to Trade Bioatla Stock guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bioatla. If investors know Bioatla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bioatla listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.70) | Revenue Per Share 0.228 | Quarterly Revenue Growth 0.316 | Return On Assets (0.50) | Return On Equity (1.39) |
The market value of Bioatla is measured differently than its book value, which is the value of Bioatla that is recorded on the company's balance sheet. Investors also form their own opinion of Bioatla's value that differs from its market value or its book value, called intrinsic value, which is Bioatla's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bioatla's market value can be influenced by many factors that don't directly affect Bioatla's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bioatla's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bioatla is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bioatla's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.